Intracellular cGMP may promote Ca2+-dependent and Ca2+-independent release of catecholamines from sympathetic nerve terminals

Vascular Pharmacology

Volumn 45, Issue 2, 2006, Pages 102-111

  Whalen, Erin J ^a,b   Saurer, Timothy B ^a   Johnson, Alan Kim ^a,b,c   Lewis, Stephen J ^d  

^a University of Iowa   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Anatomic Pathology Service Department of Veterinary Pathobiology College of Veterinary   (United States)

Author keywords

Adrenergic receptors; cGMP; Nitric oxide (NO); Norepinephrine release; Propranolol; Rat; Sympathetic nerves

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC GMP; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM; CALCIUM ION; CATECHOLAMINE; CHLORISONDAMINE; CYCLIC GMP; CYCLIC GMP DERIVATIVE; GANGLION BLOCKING AGENT; METHYLATROPINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE; PROPRANOLOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; CALCIUM TRANSPORT; CATECHOLAMINE RELEASE; CONTROLLED STUDY; HEART RATE; INTRACELLULAR TRANSPORT; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE PERMEABILITY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; SYMPATHETIC NERVE; TACHYCARDIA; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD PRESSURE; CALCIUM; CALCIUM SIGNALING; CATECHOLAMINES; CONSCIOUSNESS; CYCLIC GMP; HEART RATE; INTRACELLULAR FLUID; MALE; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHETIC NERVOUS SYSTEM; THIONUCLEOTIDES;

EID: 33748572551     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.03.006     Document Type: Article

References (70)

1. Anderson C.R., Edwards S.L., Furness J.B., Bredt D.S., and Snyder S.H. The distribution of nitric oxide synthase-containing autonomic preganglionic terminals in the rat. Brain Res. 614 (1993) 78-85
2. Ando M., Tatematsu T., Kunii S., and Nagata Y. The intercellular communication via nitric oxide and its regulation in coupling of cyclic GMP synthesis upon stimulation of muscarinic cholinergic receptors in rat superior cervical ganglia. Brain Res. 650 (1994) 283-288
3. Balligand J.L., Kobzik L., Han X., Kaye D.M., Belhassen L., O'Hara D.S., Kelly R.A., Smith T.W., and Michel T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem. 270 (1995) 14582-14586
4. Bonisch H. The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines. Naunyn Schmiedeberg's Arch. Pharmacol. 332 (1986) 135-141
5. Briggs C.A. Potentiation of nicotinic transmission in the rat superior cervical sympathetic ganglion: effects of cyclic GMP and nitric oxide generators. Brain Res. 573 (1992) 139-146
6. Brock J.A., and Cunnane T.C. Studies on the mode of action of bretylium and guanethidine in post-ganglionic sympathetic nerve fibres. Naunyn Schmiedeberg's Arch. Pharmacol. 338 (1988) 504-509
7. Bucher B., Ouedraogo S., Tschopl M., Paya D., and Stoclet J.C. Role of the l-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br. J. Pharmacol. 107 (1992) 976-982
8. Butt E., Nolte C., Schulz S., Beltman J., Beavo J.A., Jastorff B., and Walter U. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator, 8-para-chlorophenylthio-cGMP. Biochem. Pharmacol. 43 (1992) 2591-2600
9. Butt E., Eigenthaler M., and Genieser H.G. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur. J. Pharmacol. 269 (1994) 265-268
10. 2+ current inhibition in rat sympathetic neurons. J. Physiol. 482 (1995) 521-531
11. Choate J.K., and Paterson D.J. Nitric oxide inhibits the positive chronotropic and inotropic responses to sympathetic nerve stimulation in the isolated guinea-pig atria. J. Auton. Nerv. Syst. 75 (1999) 100-108
12. Cooke J.P., and Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Annu. Rev. Med. 48 (1997) 489-509
13. Davisson R.L., Johnson A.K., and Lewis S.J. Nitrosyl factors mediate active neurogenic hindquarter vasodilation in the conscious rat. Hypertension 23 (1994) 962-966
14. Davisson R.L., Bates J.N., Johnson A.K., and Lewis S.J. Use-dependent loss of acetylcholine- and bradykinin-mediated after nitric oxide synthase inhibition: evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. Hypertension 28 (1996) 354-360
15. Davisson R.L., Travis M.D., Bates J.N., Johnson A.K., and Lewis S.J. Stereoselective actions of S-nitrosocysteine in the central nervous system of conscious rats. Am. J. Physiol. 272 (1997) H2361-H2368
16. Driessen B., and Goncalves J. Inhibition of neural ATP release by atrial natriuretic peptide in guinea-pig vas deferens. Eur. J. Pharmacol. 296 (1996) 261-265
17. Egi Y., Matsumura Y., Murata S., Umekawa T., Hisaki K., Takaoka M., and Morimoto S. The effects of N-G-nitro-l-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs. J. Pharmacol. Exp. Ther. 269 (1994) 529-535
18. Farrell D.M., and Bishop V.S. The roles of cGMP and cAMP in active thermoregulatory vasodilation. Am. J. Physiol. 272 (1997) R975-R981
19. Feuerstein G., Zerbe R.L., and Faden A.I. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats. J. Pharmacol. Exp. Ther. 228 (1984) 348-353
20. Gillis C.N., and Nash C.W. The initial pressor actions of bretylium tosylate and guanethidine sulfate and their relation to release of catecholamines. J. Pharmacol. Exp. Ther. 134 (1961) 1-7
21. Gokhale S.D., Gulati O.D., and Kelkar V.V. Mechanism of the initial adrenergic effects of bretylium and guanethidine. Br. J. Pharmacol. 20 (1963) 362-377
22. Greenberg S., Diecke F.P.J., Peevy K., and Tanaka T.P. The endothelium modulates adrenergic neurotransmission to canine pulmonary arteries and veins. Eur. J. Pharmacol. 162 (1989) 67-80
23. Greenberg S.S., Diecke F.P.J., Cantor E., Peevy K., and Tanaka T.P. Inhibition of sympathetic neurotransmitter release by modulators of cyclic GMP in canine vascular smooth muscle. Eur. J. Pharmacol. 187 (1990) 409-423
24. Haass M., Hock M., Richardt G., and Schomig A. Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea pig heart. Naunyn Schmiedeberg's Arch. Pharmacol. 340 (1989) 509-515
25. Han X., Shimoni Y., and Giles W.R. An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J. Physiol. 476 (1994) 309-314
26. Humphreys P.W., and Joels N. Effect of pregnancy on pressure-volume relationships in circulation of rabbits. Am. J. Physiol. 267 (1994) R780-R785
27. Keeton T.K., and Biediger A.M. The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats. Naunyn Schmiedeberg's Arch. Pharmacol. 338 (1988) 350-360
28. Klimaschewsi L., Kummer W., Mayer B., Couraud J.Y., Preissler U., Philippin B., and Heym C. Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. Circ. Res. 71 (1992) 1533-1537
29. Komalavilas P., Shah P.K., Jo H., and Lincoln T.M. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J. Biol. Chem. 274 (1999) 34301-34309
30. Kuhn M. Molecular physiology of natriuretic peptide signalling. Basic Res. Cardiol. 99 (2004) 76-82
31. Langeloh A., and Trendelenburg U. The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline. Naunyn Schmiedeberg's Arch. Pharmacol. 336 (1987) 11-620
32. Langeloh A., Bonisch H., and Trendelenburg U. The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake 1; multifactorial induction of outward transport. Naunyn Schmiedeberg's Arch. Pharmacol. 336 (1987) 602-610
33. Locknar S.A., Calupca M.A., and Parsons R.L. Innervation of guinea-pig stellate ganglia by nitric oxide synthase, cocaine- and amphetamine-regulated transcript protein- and pituitary adenylate cyclase activating polypeptide-immunoreactive fibers. Neuroscience 112 (2002) 525-533
34. 3H]Norepinephrine release. I. The role of glutamate. J. Pharmacol. Exp. Ther. 275 (1995) 7-13
35. 3H]Norepinephrine release. II. The role of calcium, reverse norepinephrine transport and cyclic3′,5′-guanosine monophosphate. J. Pharmacol. Exp. Ther. 275 (1995) 14-22
36. Marley P.D., McLeod J., Anderson C., and Thomson K.A. Nerves containing nitric oxide synthase and their possible function in the control of catecholamine secretion in the bovine adrenal medulla. J. Auton. Nerv. Syst. 54 (1995) 184-194
37. Meffert M.K., Calakos N.C., Scheller R.H., and Schulman H. Nitric oxide modulates synaptic vesicle docking fusion reactions. Neuron 16 (1996) 1229-1236
38. Meller S.T., Lewis S.J., Ness T.J., Brody M.J., and Gebhart G.F. Neonatal capsaicin treatment abolishes the nociceptive responses to intravenous 5-HT in the rat. Brain Res. 542 (1991) 212-218
39. Misono K.S. Natriuretic peptide receptor: structure and signaling. Mol. Cell. Biochem. 230 (2002) 49-60
40. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
41. Moro M.A., Michelena P., Sanchez-Garcia P., Palmer R., Moncada S., and Garcia A.G. Activation of adrenal medullary l-arginine/nitric oxide pathway by stimuli which induce the release of catecholamines. Eur. J. Pharmacol. 246 (1993) 213-218
42. Myers P.R., Minor R.L., Guerra R., Bates J.N., and Harrison D.G. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345 (1990) 161-163
43. Nagayama T., Hosokawa A., Yoshida M., Suzuki-Kusaba M., Hisa H., Kimura T., and Satoh S. Role of nitric oxide in adrenal catecholamine secretion in anesthetized dogs. Am. J. Physiol. 275 (1998) R1075-R1081
44. Okamura H., Umehara K., Tadaki N., Hisa Y., Esumi H., and Ibata Y. Sympathetic preganglionic neuron containing nitric oxide synthase and project to the superior cervical ganglion: combined application of retrograde neuronal tracer and NADPH-diaphorase histochemistry. Brain Res. Bull. 5 (1995) 491-494
45. 2+ current increase in snail neurons. Nature 323 (1986) 812-814
46. Reis F., Rocha L., Ponte L., Alcobia T., Almeida L., Costa-Almeida C., and Teixeira F. Effect of preventive and regressive isosorbide 5-mononitrate treatment on catecholamine levels in plasma, platelets, adrenals, left ventricle and aorta in cyclosporin A-induced hypertensive rats. Life Sci. 77 (2005) 2514-2528
47. Reynaert N.L., Ckless K., Wouters E.F., Van Der Vliet A., and Janssen-Heininger Y.M. Nitric oxide and redox signaling in allergic airway inflammation. Antioxid. Redox Signal. 7 (2005) 129-143
48. 2+ influx in bovine chromaffin cells. Neuroscience 67 (1995) 149-157
49. Rodriguez-Pascual F., Miras-Portugal M.T., and Torres M. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase. Mol. Pharmacol. 49 (1996) 1058-1070
50. Rosenblum W.I. Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide. Stroke 23 (1992) 1527-1532
51. Schomig A., Fischer S., Kurz T., Richardt G., and Schomig E. Non-exocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements. Circ. Res. 60 (1987) 194-205
52. Schomig A., Kurz T.H., Richardt G., and Schomig E. Neuronal sodium homeostasis and axoplasmic amine concentrations determine calcium-independent noradrenaline release in normoxic and ischemic rat heart. Circ. Res. 63 (1988) 214-226
53. 2+-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105 (1992) 575-580
54. Schwarz P., Diem R., Dun N.J., and Forstermann U. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat sympathetic heart sympathetic nerves. Circ. Res. 77 (1995) 841-848
55. Schwarz P.M., Rodriguez-Pascual F., Koesling D., Torres M., and Forstermann U. Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells. Neuroscience 82 (1998) 255-265
56. Scott T.R., and Bennett M.R. The effect of nitric oxide on the efficacy of synaptic transmission through the chick ciliary ganglion. Br. J. Pharmacol. 110 (1993) 627-632
57. Shinozuka K., Kobayashi Y., Shimoura K., and Hattori K. Role of nitric oxide from the endothelium on the neurogenic contractile responses of the rabbit pulmonary artery. Eur. J. Pharmacol. 222 (1992) 113-120
58. Thomas C.J., and Woods R.L. Guanylyl cyclase receptors mediate cardiopulmonary vagal reflex actions of ANP. Hypertension 41 (2003) 279-285
59. Toda N., Yoshida K., and Okamura T. Analysis of the potentiating action of NG-nitro-l-arginine on the contraction of the dog temporal artery elicited by the transmural stimulation of noradrenergic nerves. Naunyn Schmiedeberg's Arch. Pharmacol. 343 (1991) 221-224
60. Travis M.D., Stoll L.L., Bates J.N., and Lewis S.J. l- and d-S-nitroso-β,β-dimethylcysteine differentially increase cGMP in cultured vascular smooth muscle cells. Eur. J. Pharmacol. 318 (1996) 47-53
61. Tremblay J., Desjardins R., Hum D., and Hamet J. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol. Cell. Biochem. 230 (2002) 31-47
62. Vo A.P., Reid J.J., and Rand M.J. Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery. Br. J. Pharmacol. 107 (1992) 1121-1128
63. 2-receptors. Eur. J. Pharmacol. 382 (1999) 207-210
64. Whalen E.J., Johnson A.K., and Lewis S.J. Blockade of β-adrenoceptors enhances cAMP signal transduction in vivo. Eur. J. Pharmacol. 355 (1998) 189-193
65. Whalen E.J., Beltz T.G., Lewis S.J., and Johnson A.K. AV3V lesions attenuate cardiovascular responses produced by blood-borne excitatory amino acid analogs. Am. J. Physiol. 276 (1999) H1409-H1415
66. Whalen E.J., Johnson A.K., and Lewis S.J. Effects of nitric oxide synthase inhibition on sympathetically-mediated tachycardia. Eur. J. Pharmacol. 365 (1999) 217-223
67. 3 receptors on vagal afferents mediating the Bezold-Jarisch reflex. Brain Res. 873 (2000) 302-305
68. Yamaguchi I., and Kopin I.J. Plasma catecholamine and blood pressure responses to sympathetic stimulation in pithed rats. Am. J. Physiol. 237 (1979) H305-H310
69. Yamamoto R., Wada A., Asada Y., Niina H., and Sumiyoshi A. N-omega-nitro-l-arginine, an inhibitor of nitric oxide synthesis, decreases noradrenaline outflow in rat isolated perfused mesenteric vasculature. Naunyn Schmiedeberg's Arch. Pharmacol. 347 (1993) 238-240
70. Yamamoto R., Wada A., Asada Y., Yuhi T., Yanagita T., Niina H., and Sumiyoshi A. Functional relation between nitric oxide and noradrenaline for the modulation of vascular tone in rat mesenteric vasculature. Naunyn Schmiedeberg's Arch. Pharmacol. 349 (1993) 362-366